Turner Investments’s Bristol-Myers Squibb BMY Stock Holding History

Turner Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,060	Closed	-$488K	–	266
2016 Q3	$488K	Sell	9,060 -45,990	-84%	-$2.95M	0.16%	144
2016 Q2	$4.05M	Sell	55,050 -18,080	-25%	-$1.28M	1.27%	25
2016 Q1	$4.67M	Buy	73,130 +1,870	+3%	+$118K	1.27%	21
2015 Q4	$4.9M	Buy	71,260 +41,090	+136%	+$2.72M	1.01%	31
2015 Q3	$1.79M	Buy	30,170 +4,270	+16%	+$271K	0.36%	94
2015 Q2	$1.72M	Buy	25,900 +7,240	+39%	+$477K	0.32%	109
2015 Q1	$1.2M	Buy	+18,660	New	+$1.17M	0.22%	139
2014 Q2	–	Sell	-182,194	Closed	-$9.46M	–	559
2014 Q1	$9.46M	Sell	182,194 -69,552	-28%	-$3.7M	0.25%	145
2013 Q4	$13.4M	Sell	251,746 -639,393	-72%	-$32.6M	0.24%	141
2013 Q3	$41.2M	Sell	891,139 -321,824	-27%	-$14.1M	0.68%	25
2013 Q2	$54.2M	Buy	+1,212,963	New	+$52.7M	0.73%	17

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Turner Investments's BMY Position: Q4 2016 in Review

Turner Investments sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 9,060 shares — an estimated $488K sold.

Turner Investments first reported a position in BMY in Q2 2013 and held it in 11 quarters. The position peaked at $54.2M in Q2 2013. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Turner Investments reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 9,060 Bristol-Myers Squibb shares in Q4 2016, an estimated $488K.
Turner Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 11 quarters.
Turner Investments's Bristol-Myers Squibb position peaked at $54.2M in Q2 2013.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.